Find your next paid study

National Center for Complementary and Integrative Health (NCCIH)NCT07504601

~$75 – $3,000

Actual pay is set by the research site.

Feasibility and Adaptation of a Hospice Transitions Checklist for Hospitalized Persons With Dementia

This is an NIH Stage IB single-arm feasibility study will adapt and test the Inpatient Hospice Transitions Checklist (I-HTC), an Epic-embedded intervention sup…

Dementia

New York UniversityNCT07889830

Actual pay is set by the research site.

Phase 1

A Phase 1 Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SHY-ONC6 in Participants With Advanced or Metastatic Solid Tumors

This is a Phase 1, first-in-human (FIH), open-label, multicenter study designed to evaluate the safety, tolerability, PK, and preliminary anti-tumor activity o…

Advanced or Metastatic Solid TumorsTriple Negative Breast Cancer (TNBC)HR+ Breast Cancer+8 more

SHY TherapeuticsNCT07705334

~$150 – $4,200

Actual pay is set by the research site.

The Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults >= 55 Years Old. A Randomized Triple-Masked Controlled Clinical Trial

Background: As people age, the cells in the pancreas that produce insulin begin to release less of this hormone, and levels of blood glucose (sugar) rise. Thi…

Healthy Volunteer

National Institute on Aging (NIA)NCT06274749

~$10 – $675

Actual pay is set by the research site.

Ventral HerniaVentral Incisional HerniaPost Operative Pain

The IMPACT Study: A Randomized Controlled Trial of Individualized Management Post Ventral Hernia Repair (VHR) Utilizing Abdominal Core Therapy for Enhanced Recovery and Health Outcomes

Ventral hernia repair is among the most common operations performed in the United States each year, yet the great majority of patients receive no structured re…

Thomas Jefferson UniversityNCT07145099

Actual pay is set by the research site.

Long Term Follow up Study for Participants Treated With an Allogeneic CAR T-Cell Product in a Prior Clinical Study

An observational, long-term follow up (LTFU) study of participants who received an allogeneic CAR T product in a prior clinical study. Participants will be fol…

Hematologic MalignanciesSolid Tumors

Allogene TherapeuticsNCT06925685

~$10 – $1,050

Actual pay is set by the research site.

Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)

Background: Exposure to smoke increases the risk of many diseases. People can be exposed to dangerous levels of smoke during wildfires. Also, smoke from fires…

AnosmiaChronic Obstructive Pulmonary DiseaseHyposmia+2 more

National Institute of Allergy and Infectious Diseases (NIAID)NCT07867184

~$10 – $675

Actual pay is set by the research site.

Phase 1

A Phase 1 Study of ARC101 in Advanced Solid Tumors

This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of ARC101 in patients with advanced cancer.

Advanced Solid Tumor

NSCLCNSCLC (Advanced Non-small Cell Lung Cancer)ES-SCLC+9 more

~$150 – $4,500

Actual pay is set by the research site.

Third Arc BioNCT06672185

Phase 1

BActinium-2: A Phase 1b, 2 Part, Multicenter, Open Label Study to Evaluate the Safety and Efficacy of Intravenous Administration of a B7-H3 Radiopharmaceutical ([225Ac]Ac AKY 2519) in Participants With B7-H3 Imaging Positive Solid Tumors

This is a Phase 1b, 2-part, multi-center, open-label study to evaluate the safety, tolerability, dosimetry, and pharmacokinetics (PK) of \[64Cu\]Cu-AKY-2519 an…

~$150 – $4,200

Actual pay is set by the research site.

Aktis Oncology, Inc.

Supine HypertensionAutonomic Failure

Impact of Decreased Venous Return on Supine Blood Pressure

Many persons with autonomic failure often have high blood pressure when lying down (supine hypertension). This study is exploring the impact of decreased venou…

Vanderbilt University Medical CenterNCT04502225

Actual pay is set by the research site.

Depression - Major Depressive DisorderPsychological DistressDepression / Major Depressive Disorder

Examining Non-Deceptive Placebo Effects on Subclinical Depression Symptoms: A Three-Arm Randomized Controlled Trial Comparing Blinded and Unblinded Control Conditions

Subclinical depression - depressive symptoms that fall below the threshold for major depressive disorder - is common in young adults and predicts later depress…

Miami UniversityNCT07889908

Actual pay is set by the research site.

Phase 3

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults With Major Depressive Disorder - Ascend

A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disord…

Major Depressive Disorder